Glyclopyramide

 Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.

Glyclopyramide
Glyclopyramide.svg
Clinical data
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
IUPAC name
  • 4-chloro-N-[(pyrrolidin-1-ylamino)carbonyl]benzenesulfonamide
CAS Number
  • 631-27-6 ☒
PubChem CID
  • 71793
ChemSpider
  • 64820 ☒
UNII
  • KE474IKG1W
KEGG
  • D01799 check
ChEMBL
  • ChEMBL2105083 ☒
CompTox Dashboard (EPA)
  • DTXSID2048822 Edit this at Wikidata
Chemical and physical data
FormulaC11H14ClN3O3S
Molar mass303.76 g·mol−1
3D model (JSmol)
  • Interactive image
SMILES
  • C1CCN(C1)NC(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl
InChI
  • InChI=1S/C11H14ClN3O3S/c12-9-3-5-10(6-4-9)19(17,18)14-11(16)13-15-7-1-2-8-15/h3-6H,1-2,7-8H2,(H2,13,14,16) ☒
  • Key:HNSCCNJWTJUGNQ-UHFFFAOYSA-N ☒
 ☒check (what is this?)  (verify)

It is classified as second generation.[1]

This article uses material from the Wikipedia article
 Metasyntactic variable, which is released under the 
Creative Commons
Attribution-ShareAlike 3.0 Unported License.